Being able to produce stem cells for clinical use is a major challenge which must be overcome if they are to fulfill their potential.  Roslin Cells will work closely with the Scottish National Blood Transfusion Service (SNBTS) to establish the Good Manufacturing Practice conditions needed for its cell lines to be of clinical grade.   The SNBTS has extensive experience of the supply of tissue products for clinical application within the NHS Scotland.

The broader mission of the Company is to support the development of stem cell technologies in Scotland. 

The Company has recently secured its initial funding package.  The first staff have been recruited and the GMP facilities are being fitted out. 

The Company expects to make further announcements in the coming months.